Nakaigawa, N., Kondo, K., Tateishi, U., Minamimoto, R., Kaneta, T., Namura, K., . . . Yao, M. (2016). FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma. BMC Cancer.
Παραπομπή Chicago StyleNakaigawa, Noboru, et al. "FDG PET/CT As a Prognostic Biomarker in the Era of Molecular-targeting Therapies: Max SUVmax Predicts Survival of Patients With Advanced Renal Cell Carcinoma." BMC Cancer 2016.
Παραπομπή MLANakaigawa, Noboru, et al. "FDG PET/CT As a Prognostic Biomarker in the Era of Molecular-targeting Therapies: Max SUVmax Predicts Survival of Patients With Advanced Renal Cell Carcinoma." BMC Cancer 2016.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.